Responsiveness of different MET tumour alterations to type I and type II MET inhibitors

Yonina R. Murciano‐Goroff, Valentina Foglizzo, Jason Chang, Natasha Rekhtman, Ann Elizabeth Sisk, Jamie Gibson, Lia Judka, Kristen Clemens, Paola Roa, Shaza Sayed Ahmed, Nicole V. Bremer, Courtney Lynn Binaco, Sherifah Kemigisha Muzungu, Estelamari Rodriguez, Madeline Merrill, Erica Sgroe, Matteo Repetto, Zsofia K. Stadler, Michael F. Berger, Helena A. Yu, Eneda Toska, Srinivasaraghavan Kannan, Chandra S. Verma, Alexander Drilon, Emiliano Cocco

Open source

DOI: 10.1002/ctm2.70338
Published: 2025-05
Container: Clinical and Translational Medicine
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ctm2.70338,
  title = {Responsiveness of different MET tumour alterations to type I and type II MET inhibitors},
  author = {Yonina R. Murciano‐Goroff and Valentina Foglizzo and Jason Chang and Natasha Rekhtman and Ann Elizabeth Sisk and Jamie Gibson and Lia Judka and Kristen Clemens and Paola Roa and Shaza Sayed Ahmed and Nicole V. Bremer and Courtney Lynn Binaco and Sherifah Kemigisha Muzungu and Estelamari Rodriguez and Madeline Merrill and Erica Sgroe and Matteo Repetto and Zsofia K. Stadler and Michael F. Berger and Helena A. Yu and Eneda Toska and Srinivasaraghavan Kannan and Chandra S. Verma and Alexander Drilon and Emiliano Cocco},
  year = {2025},
  journal = {Clinical and Translational Medicine},
  doi = {10.1002/ctm2.70338},
  url = {https://doi.org/10.1002/ctm2.70338}
}

RIS

TY  - JOUR
TI  - Responsiveness of different MET tumour alterations to type I and type II MET inhibitors
AU  - Yonina R. Murciano‐Goroff
AU  - Valentina Foglizzo
AU  - Jason Chang
AU  - Natasha Rekhtman
AU  - Ann Elizabeth Sisk
AU  - Jamie Gibson
AU  - Lia Judka
AU  - Kristen Clemens
AU  - Paola Roa
AU  - Shaza Sayed Ahmed
AU  - Nicole V. Bremer
AU  - Courtney Lynn Binaco
AU  - Sherifah Kemigisha Muzungu
AU  - Estelamari Rodriguez
AU  - Madeline Merrill
AU  - Erica Sgroe
AU  - Matteo Repetto
AU  - Zsofia K. Stadler
AU  - Michael F. Berger
AU  - Helena A. Yu
AU  - Eneda Toska
AU  - Srinivasaraghavan Kannan
AU  - Chandra S. Verma
AU  - Alexander Drilon
AU  - Emiliano Cocco
PY  - 2025
JO  - Clinical and Translational Medicine
DO  - 10.1002/ctm2.70338
UR  - https://doi.org/10.1002/ctm2.70338
ER  -

APA

Murciano‐Goroff, Y. R., Foglizzo, V., Chang, J., Rekhtman, N., Sisk, A. E., Gibson, J., Judka, L., Clemens, K., Roa, P., Ahmed, S. S., Bremer, N. V., Binaco, C. L., Muzungu, S. K., Rodriguez, E., Merrill, M., Sgroe, E., Repetto, M., Stadler, Z. K., Berger, M. F., Yu, H. A., Toska, E., Kannan, S., Verma, C. S., Drilon, A., & Cocco, E. (2025). Responsiveness of different MET tumour alterations to type I and type II MET inhibitors. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70338

Source records

crossref · retrieved 2026-09-25T05:53:14.057Z